Oral HIV-associated Kaposi sarcoma

Journal of Oral Pathology and Medicine

Volumn 42, Issue 3, 2013, Pages 201-207

  Pantanowitz, L ^a   Khammissa, R A G ^b   Lemmer, J ^b   Feller, L ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

Author keywords

AIDS; HAART; HHV8; HIV; IRIS; Kaposi sarcoma; Mouth; Mucosa; Oral

Indexed keywords

ALPHA INTERFERON; ANTHRACYCLINE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; IMATINIB; MATRIX METALLOPROTEINASE INHIBITOR; RITUXIMAB; SCLEROSING AGENT; TAXANE DERIVATIVE; THALIDOMIDE; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURGERY; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; EPITHELIUM CELL; HERPES SIMPLEX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KAPOSI SARCOMA; LYMPHEDEMA; MOUTH CANCER; NONHUMAN; ORAL BIOPSY; ORAL SURGERY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; VIRUS CARCINOGENESIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; LYMPHEDEMA; MOUTH NEOPLASMS; SARCOMA, KAPOSI;

EID: 84874701046     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2012.01180.x     Document Type: Review

References (70)

1. Pantanowitz L, Stebbing J, Dezube BJ. Overview of Kaposi sarcoma. In: Pantanowitz L, Stebbing J, Dezube BJ, eds. Kaposi sarcoma. A model of oncogenesis. Kerala, India: Research Signpost, 2010; 1-40.
2. Frezzini C, Leao JC, Porter S. Current trends of HIV disease of the mouth. J Oral Pathol Med 2005; 34: 513-31.
3. Chang Y, Cesarman E, Pessin MS, et al.Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
4. Pauk J, Huang ML, Brodie SJ, et al.Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000; 343: 1369-77.
5. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med 2000; 342: 1027-38.
6. Ensoli B, Sgadari C, Barillari G, Sirianni MC, Sturzl M, Monini P. Biology of Kaposi's sarcoma. Eur J Cancer 2001; 37: 1251-69.
7. Webster-Cyriaque J. Development of Kaposi's sarcoma in a surgical wound. N Engl J Med 2002; 346: 1207-10.
8. Feller L, Lemmer J. Oral Kaposi sarcoma. In: Pantanowitz L, Stebbing J, Dezube BJ, eds. Kaposi sarcoma: a model of oncogenesis. Kerala, India: Research Signpost, 2010; 295-303.
9. Wise F. Sarcoma of Kaposi with buccal lesion. Arch Derm Syphilol 1943; 47: 743-4.
10. Epstein JB, Cabay RJ, Glick M. Oral malignancies in HIV disease: changes in disease presentation, increasing understanding of molecular pathogenesis, and current management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 571-8.
11. Feller L, Lemmer J, Wood NH, Jadwat Y, Raubenheimer EJ. HIV-associated oral Kaposi sarcoma and HHV-8: a review. J Int Acad Periodontol 2007; 9: 129-36.
12. Feller L, Anagnostopoulos C, Wood NH, Bouckaert M, Raubenheimer EJ, Lemmer J. Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report. J Periodontol 2008; 79: 362-8.
13. Feller L, Khammissa RAG, Wood NH, Jose RJ, Lemmer J. Facial lymphoedema as an indicator of terminal disease in oral HIV-associated Kaposi sarcoma. SADJ 2010; 65: 14-8.
14. Marimo C. Epidemiology of oral Kaposi's sarcoma in Zimbabwe 1988-1997: a population-based study. Cent Afr J Med 2008; 54: 15-9.
15. Hong YK, Foreman K, Shin JW, et al.Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 2004; 36: 683-5.
16. Pantanowitz L. Kaposi sarcoma: appraisal of therapeutic agents. Cancer 2008; 112: 962-5.
17. Canon MJ, Dollard SC, Black JB, et al.Risk factors of Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. AIDS 2003; 17: 215-22.
18. Feller L, Wood NH, Lemmer J. HIV-associated Kaposi sarcoma: pathogenic mechanisms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104: 521-9.
19. Widmer IC, Erb P, Grob H, et al.Human herpesvirus 8 oral shedding in HIV-infected men with and without Kaposi sarcoma. J Acquir Immune Defic Syndr 2006; 42: 420-5.
20. Pak F, Mwakigonja AR, Kokhaei P, et al.Kaposi's sarcoma herpesvirus load in biopsies of cutaneous and oral Kaposi's sarcoma lesions. Eur J Cancer 2007; 43: 1877.
21. Johnston C, Orem J, Okuku F, et al.Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda. PLoS ONE 2009; 4: e4222.
22. de França TR, de Araújo RA, Ribeiro CM, Leao JC. Salivary shedding of HHV-8 in people infected or not by human immunodeficiency virus 1. J Oral Pathol Med 2011; 40: 97-102.
23. Leao JC, Porter S, Scully C. Human herpesvirus 8 and oral health care: an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90: 694-704.
24. Green TL, Beckstead JH, Lozada-Nur F, Silverman S Jr, Hansen LS. Histopathologic spectrum of oral Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol 1984; 58: 306-14.
25. Windle-Taylor PC, Shah N. Oropharyngeal Kaposi's sarcoma. Report of two cases and review of the literature. J Laryngol Otol 1983; 97: 1065-71.
26. Fusetti M, Chiti-Batelli S, Eibenstein A, Hueck S, Nardi F. Isolated oropharyngeal Kaposi's sarcoma in non AIDS patient: differences and similarities with spindle-cell haemangioendothelioma. J Laryngol Otol 2001; 115: 330-2.
27. Jordan RC, Regezi JA. Oral spindle cell neoplasms: a review of 307 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 717-24.
28. Pontes HA, Guimarães DM, Pontes FS, et al.Kaposi sarcoma and paracoccidioidomycosis in the same fragment of oral mucosa biopsy: a rare association in human immunodeficiency virus-positive patient. A case report. Diagn Microbiol Infect Dis 2011; 69: 196-9.
29. Pantanowitz L, Otis CN, Dezube BJ. Immunohistochemistry in Kaposi's sarcoma. Clin Exp Dermatol 2010; 35: 68-72.
30. Cheuk W, Wong KO, Wong CS, Dinkel JE, Ben-Dor D, Chan JK. Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers. Am J Clin Pathol 2004; 121: 335-42.
31. Ramírez-Amador V, Martínez-Mata G, González-Ramírez I, Anaya-Saavedra G, de Almeida OP. Clinical, histological and immunohistochemical findings in oral Kaposi's sarcoma in a series of Mexican AIDS patients. Comparative study. J Oral Pathol Med 2009; 38: 328-33.
32. Mwakigonja AR, Pak F, Pyakurel P, et al.Oral Kaposi's sarcoma in Tanzania: presentation, immunopathology and human herpesvirus-8 association. Oncol Rep 2007; 17: 1291-9.
33. Hassman LM, Ellison TJ, Kedes DH. KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation. J Clin Invest 2011; 121: 752-68.
34. Sullivan RJ, Pantanowitz L, Casper C, Stebbing J, Dezube BJ. HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis 2008; 47: 1209-15.
35. Pantanowitz L, Dezube BJ. Kaposi's sarcoma: progression, exacerbation and regression. Cancer Res J 2008; 2: 111-21.
36. Gambardella RJ. Kaposi's sarcoma and its oral manifestations. Oral Surg Oral Med Oral Pathol 1974; 38: 591-9.
37. Meyers AD, Barker C, Grossman R, Potsic WP, Jafek BW. Kaposi's sarcoma of the oropharynx following renal transplantation. Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol 1976; 82: 560-2.
38. Beckstead JH. Oral presentation of Kaposi's sarcoma in a patient without severe immunodeficiency. Arch Pathol Lab Med 1992; 116: 543-5.
39. Reis-Filho JS, Souto-Moura C, Lopes JM. Classic Kaposi's sarcoma of the tongue: case report with emphasis on the differential diagnosis. J Oral Maxillofac Surg 2002; 60: 951-4.
40. Bottler T, Kuttenberger J, Hardt N, Oehen HP, Baltensperger M. Non-HIV-associated Kaposi's sarcoma of the tongue. Case report and review of the literature. Int J Oral Maxillofac Surg 2007; 36: 1218-20.
41. Hiatt KM, Nelson AM, Lichy JH, Fanburg-Smith JC. Classic Kaposi Sarcoma in the United States over the last two decades: a clinicopathologic and molecular study of 438 non-HIV-related Kaposi Sarcoma patients with comparison to HIV-related Kaposi Sarcoma. Mod Pathol 2008; 21: 572-82.
42. Gorsky M, Epstein JB. A case series of acquired immunodeficiency syndrome patients with initial neoplastic diagnoses of intraoral Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90: 612-7.
43. Feller L, Khammissa RAG, Gugushe TS, et al.HIV-associated Kaposi sarcoma in African children. SADJ 2010; 65: 20-2.
44. Petit JC, Ripamonti U, Hille J. Progressive changes of Kaposi's sarcoma of the gingiva and palate. Case report in an AIDS patient. J Periodontol 1986; 57: 159-63.
45. Barrett AP, Bilous AM, Buckley DJ, Kefford RF, Packham DR. Clinicopathological presentations of oral Kaposi's sarcoma in AIDS. Aust Dent J 1988; 33: 395-9.
46. Lager I, Altini M, Coleman H, Ali H. Oral Kaposi's sarcoma: a clinicopathological study from South Africa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96: 710.
47. Kalpidis CD, Lysitsa SN, Lombardi T, Kolokotronis AE, Antoniades DZ, Samson J. Gingival involvement in a case series of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. J Periodontol 2006; 77: 523-33.
48. Shiboski CH, Winkler JR. Gingival Kaposi's sarcoma and periodontitis. A case report and suggested treatment approach to the combined lesions. Oral Surg Oral Med Oral Pathol 1993; 76: 49-53.
49. Ficarra G, Berson AM, Silverman S Jr, et al.Kaposi's sarcoma of the oral cavity: a study of 134 patients with a review of the pathogenesis, epidemiology, clinical aspects, and treatment. Oral Surg Oral Med Oral Pathol 1988; 66: 543-50.
50. Reichart PA, Langford-Kuntz A, Pohle HD. Epidemic oro-facial Kaposi's sarcoma (eKS)-report on 124 cases. Eur J Cancer B Oral Oncol 1993; 29B: 187-9.
51. Reichart PA, Khongkhunthian P, Bendick C. Oral manifestations in HIV-infected individuals from Thailand and Camobodia. Med Microbiol Immunol 2003; 192: 157-60.
52. Lausten LL, Ferguson BL, Barker BF, Cobb CM. Oral Kaposi sarcoma associated with severe alveolar bone loss: case report and review of the literature. J Periodontol 2003; 74: 1668-75.
53. Langford A, Pohle HD, Reichart P. Primary intraosseous AIDS-associated Kaposi's sarcoma. Report of two cases with initial jaw involvement. Int J Oral Maxillofac Surg 1991; 20: 366-8.
54. Nichols CM, Flaitz CM, Hicks MJ. Primary intraosseous Kaposi's sarcoma of the maxilla in human immunodeficiency virus infection: review of literature and report of case. J Oral Maxillofac Surg 1995; 53: 325-9.
55. Rohrmus B, Thoma-Greber EM, Bogher JR, Röcken M. Outlook in oral and cutaneous Kaposi's sarcoma. Lancet 2000; 356: 2160.
56. Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 1989; 7: 1201-7.
57. Bergfeld WF, Zemtsov A, Lang RS. Differentiation between AIDS-related and non-AIDS-related Kaposi's sarcoma. Cleve Clin J Med 1987; 54: 315-9.
58. Papagatsia Z, Jones J, Morgan P, Tappuni AR. Oral Kaposi sarcoma: a case of immune reconstitution inflammatory syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 70-5.
59. Feller L, Lemmer J. Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma. Infect Agent Cancer 2008; 8: 1.
60. Weir A, Wansbrough-Jones M. Mucosal Kaposi's sarcoma following protease inhibitor therapy in an HIV-infected patient. AIDS 1997; 11: 1895-6.
61. Bower M, Nelson M, Young AM, et al.Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 2005; 23: 5224-8.
62. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005; 5: 361-73.
63. Feller L, Masipa JN, Wood NH, Raubenheimer EJ, Lemmer J. The prognostic significance of facial lymphoedema in HIV-seropositive subjects with Kaposi sarcoma. AIDS Res Ther 2008; 5: 2.
64. Konstantinopoulos PA, Dezube BJ, Pantanowitz L. Morphologic and immunophenotypic evidence of in-situ Kaposi's sarcoma. BMC Clin Pathol 2006; 6: 7.
65. Bossuyt L, Van den Oord JJ, Degreef H. Lymphangioma-like variant of AIDS-associated Kaposi's sarcoma with pronounced edema formation. Dermatology 1995; 190: 324-6.
66. Epstein JB. Treatment of oral Kaposi sarcoma with intralesional vinblastine. Cancer 1993; 71: 1722-5.
67. Baccaglini L, Atkinson JC, Patton LL, Glick M, Ficarra G, Peterson DE. Management of oral lesions in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103(Suppl): S50.e1-23.
68. Dezube BJ, Pantanowitz L, Aboulafia DM. Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment. AIDS Read 2004; 14: 236-53.
69. Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L, Di Trolio R, De Placido S, Dezube BJ. Management of AIDS-related Kaposi's sarcoma. Lancet Oncol 2007; 8: 167-76.
70. Aboulafia DM. Evaluation and management of patients with Kaposi sarcoma. In: Pantanowitz L, Stebbing J, Dezube BJ, eds. Kaposi sarcoma. A model of oncogenesis. Kerala, India: Research Signpost, 2010; 339-60.